Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Linzess
Linzess
FDA approves 1st pediatric drug for functional constipation
Beckers Hospital Review
Tue, 06/13/23 - 10:58 pm
Ironwood Pharmaceuticals
FDA
Linzess
pediatric
constipation
The doctor will Zoom you now: Pharma execs talk ins and outs of telehealth
Fierce Pharma
Fri, 10/30/20 - 10:45 am
telehealth
telemedicine
Ironwood Pharmaceuticals
Evofem Biosciences
Linzess
Phexxi
pharma marketing
Ironwood, AbbVie add 'bloating' and 'discomfort' to Linzess label to reach more IBS-C patients
Fierce Pharma
Fri, 10/9/20 - 10:55 am
Ironwood
AbbVie
Linzess
IBS-C
FDA
Ironwood, Allergan adds a slate of PhIIIb data to its Linzess pitch for physicians, patients
Endpoints
Wed, 06/19/19 - 09:49 am
Ironwood Pharmaceuticals
Allergan
Linzess
clinical trials
IBS-C
14 Drugs Earn Billions for These Massachusetts Biotechs
BioSpace
Wed, 03/6/19 - 09:59 am
Massachusetts
Boston
Biogen
Tecfidera
Benepali
Shire
Takeda
Vyvanse
Vertex Pharmaceuticals
Orkambi
Kalydeco
Alexion
Soliris
Strensiq
Sanofi Genzyme
Lantus
Ironwood Pharmaceuticals
Linzess
Ironwood, Allergan set to resolve LINZESS patent litigation with Mylan
Pharmaceutical Business Review
Thu, 01/3/19 - 09:40 am
Ironwood Pharmaceuticals
Mylan
patents
Linzess
Linzess Receives Additional Indication in Japan for Chronic Constipation
CP Wire
Tue, 08/21/18 - 10:05 am
Linzess
Astellas
Ironwood
chronic constipation
Linzess Receives Additional Indication in Japan for Chronic Constipation
Tue, 08/21/18 - 09:38 am
Astellas
Ironwood Pharmaceuticals
Linzess
Ironwood Initiates Ph III Study of Linaclotide in IBS-C
CP Wire
Mon, 07/16/18 - 09:08 am
Ironwood Pharmaceuticals
Allergan
linaclotide
Linzess
IBS-C
Ironwood Initiates Ph III Study of Linaclotide in IBS-C
Mon, 07/16/18 - 09:06 am
Ironwood Pharmaceuticals
Allergan
linaclotide
Linzess
IBS-C
Allergan: Is Linzess 'Restasis 2.0'?
NY Shock Exchange
Mon, 10/23/17 - 09:42 am
Allergan
Restasis
patents
Linzess
Ironwood Pharmaceuticals
Teva Pharmaceutical
IBS-C
3 Big Battles Brewing in Biotech
Motley Fool
Sun, 04/10/16 - 01:50 pm
AstraZeneca
ZS-9
Relypsa
Veltassa
Synergy Pharmaceuticals
plecanatide
Linzess
Ironwood
Allergan
Incyte
Eli Lilly
baricitinib
AbbVie
Humira
Ironwood exec's brainstorm gives Allergan a marketing edge with Linzess
Fierce Pharma Marketing
Thu, 04/7/16 - 09:44 pm
Ironwood Pharmaceuticals
Allergan
Linzess
Is This Ironwood Pharmaceuticals' Biggest Threat?
Motley Fool
Mon, 03/21/16 - 09:11 am
Ironwood Pharmaceuticals
Linzess
plecanatide
Synergy Pharmaceuticals
Ironwood marks rare milestone: 1 million patients have taken Linzess
Bizjournals.com
Thu, 02/18/16 - 05:53 pm
Ironwood Pharmaceuticals
Linzess
IBS-C
Does Synergy Pharma's Plecanatide Blow Away The Competition?
Seeking Alpha
Fri, 07/17/15 - 10:08 am
Synergy Pharmaceuticals
IBS-C
plecanatide
Linzess
Ironwood
Next DTC push for Linzess: Spotlight patients, with big salesforce backup
Fierce Pharma Marketing
Thu, 04/9/15 - 10:02 am
Actavis
Ironwood
DTC
Linzess
IBS-C
Companies Betting on the Next 10 Blockbuster Drugs
24/7WallStreet
Wed, 04/23/14 - 11:57 am
Juxtapid
Otezla
Aegerion
Celgene
GW Pharma
Sativex
Intercept Pharma
OCA
Ironwood Pharmaceuticals
Linzess
Lpath
iSONEP
MannKind
Afrezza
Xtandi
H.P. Acthar Gel
Questcor Pharmaceuticals
eteplirsen
Sarepta Therapeutics
Previous Data Signals Positive Phase IIb Results Likely To Come For Synergy Pharmaceuticals
Seeking Alpha
Fri, 02/21/14 - 11:19 am
Synergy Pharmaceuticals
IBS-C
Ironwood Pharmaceuticals
Linzess
Sucampo
plecanatide
The Compelling Science Behind Synergy
Seeking Alpha
Mon, 04/29/13 - 11:33 am
Synergy Pharmaceuticals
plecanatide
Ironwood
Linzess
Pages
1
2
next ›
last »